Results overview: Found 4 records in 0.03 seconds.
Articles, 4 records found
Articles 4 records found  
1.
10 p, 1.4 MB Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent : 5-year results of the CENTURY II randomized clinical trial / Iñiguez, Andrés (Hospital Alvaro Cunqueiro, University Hospital of Vigo) ; Chevalier, Bernard (Institut Cardiovasculaire Paris Sud) ; Richardt, Gert (Segeberger Kliniken) ; Neylon, Antoinette (SAOLTA Health Care Group, Galway University Hospital and NUI) ; Jiménez, Victor A. (Hospital Alvaro Cunqueiro, University Hospital of Vigo) ; Kornowski, Ran (Rabin Medical Centre, Petah Tikva, Israel and Sackler Faculty of Medicine, Tel Aviv University) ; Carrie, Didier (Rangueil University Hospital) ; Moreno, Raul (La Paz University Hospital) ; Barbato, Emanuele (University of Naples Federico II) ; Serra-Peñaranda, Antoni (Institut d'Investigació Biomèdica Sant Pau) ; Guiducci, Vincenzo (Interventional Cardiology Unit, S. Maria Nuova Hospital) ; Valdés-Chávarri, Mariano (Cardiology Department, Hospital Universitario Virgen de la Arrixaca, IMIB-Arrixaca) ; Yajima, Junji (Department of Cardiovascular Medicine, The Cardiovascular Institute) ; Wijns, William (The Lambe Institute) ; Saito, Shigeru (Shonan Kamakura General Hospital) ; Universitat Autònoma de Barcelona
To assess the long-term safety and efficacy of a sirolimus-eluting stent with bioresorbable polymer (BP-SES; Ultimaster), in comparison to a benchmark everolimus-eluting, permanent polymer stent (PP-EES; Xience), in a prespecified subgroup of patients with multivessel coronary artery disease (MVD) enrolled in the CENTURY II trial. [...]
2019 - 10.1002/ccd.28224
Catheterization and Cardiovascular Interventions, Vol. 95 (april 2019) , p. 175-184  
2.
7 p, 365.1 KB Safety of cilostazol in peripheral artery disease : a cohort from a primary healthcare electronic database / Real, Jordi (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Serna, M Catalina (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Giner Soriano, Maria (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Forés, Rosa (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Pera, Guillem (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Ribes, Esther (Direcció d'Atenció Primària Lleida. Institut Català de la Salut) ; Alzamora, Maite (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Marsal, Josep Ramon (Hospital Universitari Vall d'Hebron) ; Heras, Antonio (Institut Català de la Salut. Centre d'Atenció Primària Riu Nord-Riu Sud Santa Coloma de Gramenet) ; Morros, Rosa (Institut Universitari d'Investigació en Atenció Primària Jordi Gol) ; Universitat Autònoma de Barcelona
Cilostazol has been associated with spontaneous reports of cardiovascular adverse events and serious bleeding. The objective of this study is to determine the relative risk of cardiovascular adverse events or haemorrhages in patients with peripheral artery disease treated with cilostazol in comparison to pentoxifylline users. [...]
2018 - 10.1186/s12872-018-0822-4
BMC Cardiovascular disorders, Vol. 18 (may 2018)  
3.
10 p, 365.3 KB Hospital and 4-year mortality predictors in patients with acute pulmonary edema with and without coronary artery disease / Figueras Bellot, Jaume (Hospital Universitari Vall d'Hebron. Servei de Cardiologia) ; Bañeras Rius, Jordi (Hospital Universitari Vall d'Hebron. Servei de Cardiologia) ; Peña-Gil, Carlos (Complexo Hospitalario Universitario de Vigo. Servicio de Cardiología) ; Barrabés Riu, José Antonio (Hospital Universitari Vall d'Hebron. Servei de Cardiologia) ; Rodríguez Palomares, José Fernando (Hospital Universitari Vall d'Hebron. Servei de Cardiologia) ; Garcia Dorado, David (Hospital Universitari Vall d'Hebron. Servei de Cardiologia) ; Universitat Autònoma de Barcelona
Long-term prognosis of acute pulmonary edema () remains ill defined. We evaluated demographic, echocardiographic, and angiographic data of 806 consecutive patients with with () and without coronary artery disease (non-) admitted from 2000 to 2010. [...]
2016 - 10.1161/JAHA.115.002581
Journal of the American Heart Association, Vol. 5, issue 2 (Feb. 2016)  
4.
6 p, 339.5 KB Nuclear medicine in the management of patients with heart failure : guidance from an expert panel of the International Atomic Energy Agency (IAEA) / Peix, Amalia (Instituto de Cardiología y Cirugía Cardiovascular, Havana, Cuba) ; Mesquita, Claudio Tinoco (Hospital Universitário Antonio Pedro, Universidade Federal Fluminense (UFF), Niteroi) ; Paez, Diana (Department of Nuclear Sciences and Applications, Division of Human Health, Section of Nuclear Medicine and Diagnostic Imaging, International Atomic Energy Agency, Vienna, Austria) ; Pereira, Carlos Cunha (Quanta Diagnostico Nuclear, Curitiba) ; Felix, Renata (Instituto Nacional de Cardiologia, Rio de Janeiro) ; Gutierrez, Claudia (Fundación Cardioinfantil, Instituto de Cardiología, Bogotá) ; Jaimovich, Rodrigo (Hospital Clínico, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile) ; Ianni, Barbara Maria (Instituto do Coração, Universidade de São Paulo, São Paulo, Brazil) ; Soares, Jose (Instituto do Coração, Universidade de São Paulo, São Paulo, Brazil) ; Olaya, Pastor (Fundación Clínica Valle Del Lili, Cali, Colombia) ; Rodriguez, Ma. Victoria (Hospital General de Coro, Coro, Venezuela) ; Flotats, Albert (Institut d'Investigació Biomèdica Sant Pau) ; Giubbini, Raffaele (Cattedra e U.O. di Medicina Nucleare, Università e Spedali Civili, Brescia, Italy) ; Travin, Mark (Montefiore Medical Center, Yeshiva University, New York, New York) ; Garcia, Ernest V. (Department of Radiology, Emory University Hospital, Emory University School of Medicine, Atlanta, Georgia, USA) ; Universitat Autònoma de Barcelona
Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. [...]
2014 - 10.1097/MNM.0000000000000143
Nuclear Medicine Communications, Vol. 35 (july 2014) , p. 818-823  

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.